A 58-year-old patient with type 2 diabetes presents with new hypertension. Which medication is most appropriate to start to address both blood pressure and diabetic kidney protection?

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

A 58-year-old patient with type 2 diabetes presents with new hypertension. Which medication is most appropriate to start to address both blood pressure and diabetic kidney protection?

Explanation:
ACE inhibitors are preferred when a patient has diabetes and hypertension because they lower blood pressure and protect the kidneys by reducing angiotensin II–mediated pressure in the glomerulus. This lowers intraglomerular pressure and proteinuria, slowing diabetic kidney disease progression while also providing BP control. Among the options, ramipril is an ACE inhibitor with well-established renoprotective effects in diabetes, making it the best choice to address both goals with one medicine. The other drugs listed either don’t offer the same kidney protection (a calcium channel blocker) or mainly reduce BP without renoprotection (a thiazide), so they’re not as ideal as a first-line option for dual benefit. After starting, monitor kidney function and potassium, and be mindful of interactions and contraindications such as pregnancy or bilateral renal artery stenosis.

ACE inhibitors are preferred when a patient has diabetes and hypertension because they lower blood pressure and protect the kidneys by reducing angiotensin II–mediated pressure in the glomerulus. This lowers intraglomerular pressure and proteinuria, slowing diabetic kidney disease progression while also providing BP control. Among the options, ramipril is an ACE inhibitor with well-established renoprotective effects in diabetes, making it the best choice to address both goals with one medicine. The other drugs listed either don’t offer the same kidney protection (a calcium channel blocker) or mainly reduce BP without renoprotection (a thiazide), so they’re not as ideal as a first-line option for dual benefit. After starting, monitor kidney function and potassium, and be mindful of interactions and contraindications such as pregnancy or bilateral renal artery stenosis.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy